Hello! Welcome to Zhong Jian Lian Biomedical Technology (Sichuan) Co., Ltd.
Director of Deyang economic and Technological Development Zone
Zhong Jian Lian Biomedical Technology (Sichuan) Co., Ltd.

Deyang Municipal Party Committee Deputy Secretary and Mayor

Date:2018.09.27 Copyfrom:This station Hits:554

On September 18, 2018, Deputy Secretary of the Municipal Party Committee and Mayor He Li met with Gao Zhonghua, the person in charge of the Deyang International Biomedical Industry Incubation Park project and the chairman of China Health Union Biomedical Technology (Sichuan) Co., Ltd. and other experts in Chengdu. Guest and host The two parties conducted cordial and friendly exchanges and communications on the development of the Deyang Biopharmaceutical Industry. Liu Huiying, Deputy Secretary of the Municipal Party Committee, Lan Yimin, Member of the Standing Committee of the Municipal Party Committee and Deputy Mayor, Xu Shuangquan, Director of the Administrative Committee of Deyang Economic Development Zone, and Wang Hong, Director of Deyang Investment Promotion Bureau Attend the meeting.



During the meeting, He Li, on behalf of the municipal party committee and the municipal government, extended a warm welcome to Gao Zhonghua, chairman of China Health Union Bio-Group and other scientists, for coming to Chengdu to participate in the West Expo, and reached a consensus after cordial conversation with Gao Zhonghua and the scientists. He said that Deyang has obvious geographical advantages and convenient transportation. It is a major equipment manufacturing base in the country, with a solid industrial foundation, profound cultural heritage and a good business environment. We warmly welcome scientists to invest and start businesses in Deyang, and hope to cooperate in key areas such as genetic engineering, biomedicine, and health industry. The Deyang Municipal Party Committee and the municipal government will give priority to policies and element guarantees, and do their best to support them. Promote the implementation of the project in Deyang to achieve mutual benefit and win-win results.




Afterwards, Gao Zhonghua, Chairman of China Health Union Biological Group, reported the construction of the park project to Mayor He Li and other city leaders. He said that the reason why he chose to invest in the project in Deyang was first because of his hometown feelings, and second, Deyang's unique regional advantages and good Natural environment and business environment. Afterwards, the experts introduced their respective projects to Mayor He Li and other city leaders, and they were fully affirmed by Mayor He Li. He said that I am also a PhD in life sciences and know that biomedicine has a long period of time. The risk is high, but the profit is high. The so-called high risk and high return are also new economic growth points in the future. Deyang is in a critical period of transformation and upgrading. The development of the biomedical industry is highly valued by the Deyang Municipal Party Committee and the government, and hopes that scientists will research and market Combining them, making full use of market and financial levers to transform the results for the benefit of mankind. The company will also make use of its rich experience in the research and development of new Chinese medicines for top international biopharmaceutical companies and the experience of a mature new drug screening integrated incubation platform. Now it has established an integrated incubation of more than 11,000 square meters of new drug screening and optimization with independent intellectual property rights in Deyang. Platforms and laboratories (hereinafter referred to as the incubation platform) to strengthen the biomedicine R&D ecosystem and industrial chain in Deyang and the western region, through international high-end supporting services and improve the western region’s biomedicine research and development capabilities, to enable the western region’s biomedicine research and development The level has reached the international level, contributing to the development of Deyang's 100 billion biomedicine.


Copyright © 2020 Zhong Jian Lian Biomedical Technology (Sichuan) Co., Ltd. All Rights Reserved 蜀ICP备:18025241-2号